When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADPT - Sell-siders bullish on BridgeBio in premarket analyst action
Adaptive Biotechnologies Corporation
Bridgebio Pharma (NASDAQ:BBIO) initiated with Buy rating and $42 (53% upside) price target at Goldman Sachs. Initiated with Buy rating and $38 price target at Jefferies. Initiated with Outperform rating and $49 price target at BMO. Initiated with Outperform rating and $34 price target at SVB Leerink. Initiated with Overweight rating and $38 price target at JPMorgan. Initiated with Overweight rating and $50 price target at Piper Jaffray.
More news on: BridgeBio Pharma, Inc., Adaptive Biotechnologies Corporation, Change Healthcare Inc., Healthcare stocks news, Stocks on the move, ,